SEC Form 10-K filed by BIO-key International Inc.
$BKYI
Computer Software: Prepackaged Software
Technology
Unavailable
Unavailable
Save time and jump to the most important pieces.
HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the
LISBON, Portugal and HOLMDEL, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, today announced a strategic partnership with Arrow ECS Iberia, a leading cybersecurity and enterprise IT solutions, value-added distributor in Spain and Portugal. Through this collaboration, Arrow ECS Iberia joins BIO-key's Channel Alliance Partner program, expanding the availability of BIO-key's cutting-edge IAM solutions across the Iberian market. With the increasing demand for robust, regul
HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
S-1 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien
WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key
WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces
HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta
HOLMDEL, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2024 investor call Thursday, March 27th at 10 a.m. ET. Results will be released before the market opens on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Conference Call Details Date / Time:Thursday, March 27th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 674731
HOLMDEL, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its third quarter ended September 30, 2024 (Q3'24). BIO-key's 2023 Q3 and nine month results were restated and filed with the Company's 2023 Form 10-K and are reflected in this release. BIO-key will host an investor call tomorrow, Friday, November 15th at 10:00am ET (details below). Financial Highlights Q3'24 revenues rose 18% to $2.1M from $1.8M in Q3'23, principally du